Antimicrobial Catheter Market Growth Accelerated by Increased Adoption of Urinary Catheters
 |
| Antimicrobial Catheter Market |
Catheters are medical tubes that
are inserted into the body to drain fluids from or infuse substances into the
body. Antimicrobial catheters have antimicrobial agents that help prevent the
risk of catheter-associated urinary tract infections (CAUTIs). CAUTIs occur in
5-10% of patients with an indwelling urinary catheter and are the most common
healthcare-associated infection. The growing geriatric population and
increasing number of surgical procedures are enhancing the risk of healthcare
associated infections, thereby driving the demand for antimicrobial catheters.
The global antimicrobial catheter
market is estimated to be valued at US$
14505.18 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market Dynamics:
One of the major drivers of the
antimicrobial catheter market growth is the rising prevalence of hospital
acquired infections. Hospital acquired infections, also known as nosocomial
infections, are those infections that patients acquire during the course of
treatment for other conditions within a healthcare setting. It is estimated
that over 5% of patients in developed countries and 15% of patients in
developing countries acquire at least one nosocomial infection.
Catheter-associated urinary tract infections are one of the most common types
of hospital acquired infections. The risk of CAUTIs can be significantly
reduced with the use of antimicrobial catheters. Another driver propelling the
market growth is the increasing surgical procedures that require catheter
placements. With the rising obese population undergoing bariatric surgeries and
number of orthopedic and cardiovascular procedures, the demand for
antimicrobial catheters is growing substantially.
SWOT Analysis
Strength: Antimicrobial catheters
help prevent catheter-associated urinary tract infections (CAUTIs), one of the
most common hospital-acquired infections. By inhibiting the growth and colonization
of microbes on the catheter, they significantly reduce infection risks for
patients. Early detection and prevention of infections also helps lower
healthcare costs.
Weakness: Traditional
antimicrobial coatings like silver and antibiotics have issues with resistance
development over time. Microbes keep evolving defenses against such mechanisms.
Some coatings also interact adversely with other medical devices or drugs.
Limited efficacy periods require frequent catheter changes.
Opportunity: Promising new
technologies using probiotics, biofilms, and phages offer more targeted and
durable infection prevention without resistance concerns. Live bacterial
interference and synergies between different protective mechanisms show high
potential. Developing economies and aging populations will drive greater demand
for safer long-term catheterization solutions.
Threats: Stringent regulatory
compliances delay market approvals and increase costs. Access to clinical trial
subjects and funding challenges hinder research. Commoditization of commodity
coatings increases price pressures on suppliers. Shift towards non-catheter
alternatives and intermittent catheterization where feasible also impacts sales
opportunities.
Key Takeaways
The Global
Antimicrobial Catheter Market Size is expected to witness high growth
over the forecast period of 2024 to 2031 supported by increasing prevalence of
hospital-acquired infections, growing aging population undergoing long-term
catheterization, and advancements in technologies. The market size is projected
to reach US$ 14505.18 Mn by 2031 from
US$ 8154.53 Mn in 2024, registering a
CAGR of 11% during the forecast period.
Regional analysis: North America currently dominates the market
owing to the large patient pool undergoing catheter-related procedures, rising
healthcare expenditure, stringent hospital safety regulations, and presence of
leading market players. However, Asia Pacific is likely to emerge as the
fastest growing regional market supported by improving access to healthcare
infrastructures and services across developing nations, and increasing focus on
preventing device-associated infections.
Key players: Key players operating in the antimicrobial catheter
market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia),
Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience,
A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours,
Inc. Companies are focused on introducing novel surfaces and coating
technologies leveraging probiotics, biofilms and phages to provide durable and
resistance-proof infection prevention solutions.
Get More Insights Here
https://masstamilan.tv/industrial-dryers-advancing-process-efficiency-in-manufacturing-industries/
https://www.newsanalyticspro.com/antimicrobial-catheter-market-size-share-growth-outlook-2023/
Comments
Post a Comment